Proton beam therapy is an advanced form of external radiotherapy that uses high-energy proton beams instead of photon x-ray beams or electrons. Carefully measured doses of protons are delivered to the precise area needing treatment, using the latest IBA ProteusONE technology. This ensures that the delivery of proton beam therapy is highly accurate and prevents the risk of radiation reaching surrounding healthy tissue.
Radiotherapy is used to kill and destroy cancer cells. It utilises radiation in the form of high-energy x-rays, known as photons, to kill and damage the cancerous cells and prevent their growth and reproduction. It can be used as a non-surgical option to treat cancer, and it can also be used to shrink a tumour or in combination with other treatments.
The Rutherford Cancer Centres and Elekta are bringing the next generation of personalised adaptive radiotherapy technology to oncology centres across the UK, with the new MR-linac Elekta Unity now available at the Rutherford Cancer Centre North West in Liverpool.
Mr Robert Thomas graduated from Newcastle University in 2008 and completed his specialist training in the North East.
Following his CCT (Certificate of Completion of Training) in 2019, he spent 6 months as a fellow in Glasgow specialising in oncoplastic breast surgery and revisional breast implant surgery. He returned to Newcastle to take up his appointment as a Consultant Oncoplastic Breast Surgeon at the Royal Victoria Infirmary, Newcastle upon Tyne.
Robert Thomas has a variety of clinical interests which include the management of breast cancer in older persons and advanced oncoplastic and revisional breast surgery.
Association of Breast Surgeons
Fellow of the Royal College of Surgeons of Edinburgh
Mr Robert Thomas does not hold a share or financial interest in the Rutherford Cancer Centres or another Rutherford Health plc company.
Mr Robert Thomas does not have a share or financial interest in equipment used at the Rutherford Cancer Centres or another Rutherford Health plc company.
Mr Robert Thomas does not hold any paid advisory role(s) at the Rutherford Cancer Centres or on behalf of Rutherford Cancer Centres or Rutherford Health plc.